Stock ETNB 89BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart 89bio, Inc.

Equities

ETNB

US2825591033

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-15 EDT 		5-day change 1st Jan Change
9.2 USD +1.21% Intraday chart for 89bio, Inc. +1.88% -17.64%
05-14 89Bio Initiates Phase 3 Enlighten-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis Patients with Compensated Cirrhosis CI
05-10 HC Wainwright Adjusts 89bio's Price Target to $29 From $31, Maintains Buy Rating MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
89BIO, INC.
Bio Therapeutic Drugs
+1.21%+1.88%-17.64%-48.52% - 894M
Neutral
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. ETNB Stock
  4. Charts 89bio, Inc.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW